Frederic M Quitkin

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. ncbi Are there differences between women's and men's antidepressant responses?
    Frederic M Quitkin
    Department of Therapeutics, New York State Psychiatric Institute and Columbia University College of Physicians and Surgeons, New York 10032, USA
    Am J Psychiatry 159:1848-54. 2002
  2. ncbi When should a trial of fluoxetine for major depression be declared failed?
    Frederic M Quitkin
    Department of Therapeutics, New York State Psychiatric Institute, New York, NY 10032, USA
    Am J Psychiatry 160:734-40. 2003
  3. ncbi Predictors of relapse in a prospective study of fluoxetine treatment of major depression
    Patrick J McGrath
    Depression Evaluation Service, New York State Psychiatric Institute, 1051 Riverside Dr, New York, NY 10032 1007, USA
    Am J Psychiatry 163:1542-8. 2006
  4. ncbi Remission rates with 3 consecutive antidepressant trials: effectiveness for depressed outpatients
    Frederic M Quitkin
    Department of Therapeutics, Columbia University College of Physicians and Surgeons, New York State Psychiatric Institute, New York, USA
    J Clin Psychiatry 66:670-6. 2005
  5. ncbi Electroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: pre- and post-treatment findings
    Gerard E Bruder
    Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York, New York, USA
    Biol Psychiatry 63:1171-7. 2008
  6. ncbi Psychomotor slowing as a predictor of fluoxetine nonresponse in depressed outpatients
    Bonnie P Taylor
    Depression Evaluation Service, New York State Psychiatric Institute, Department of Psychiatry, Columbia University College of Physicians and Surgeons, 1051 Riverside Dr, New York, NY 10032, USA
    Am J Psychiatry 163:73-8. 2006
  7. ncbi Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions
    Jonathan W Stewart
    New York State Psychiatric Institute, United States Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY, USA
    J Affect Disord 86:161-7. 2005
  8. ncbi Dichotic listening tests of functional brain asymmetry predict response to fluoxetine in depressed women and men
    Gerard E Bruder
    Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Neuropsychopharmacology 29:1752-61. 2004
  9. ncbi Do age of onset and course of illness define biologically distinct groups within atypical depression?
    Jonathan W Stewart
    Department of Therapeutics, New York State Psychiatric Institute and Columbia University College of Physicians and Surgeons, USA
    J Abnorm Psychol 112:253-62. 2003
  10. ncbi Do age of onset and course of illness predict different treatment outcome among DSM IV depressive disorders with atypical features?
    Jonathan W Stewart
    New York State Psychiatric Institute, New York, NY 10032, USA
    Neuropsychopharmacology 26:237-45. 2002

Detail Information

Publications26

  1. ncbi Are there differences between women's and men's antidepressant responses?
    Frederic M Quitkin
    Department of Therapeutics, New York State Psychiatric Institute and Columbia University College of Physicians and Surgeons, New York 10032, USA
    Am J Psychiatry 159:1848-54. 2002
    ..The study examined a large data set to determine whether patients' sex affected the outcome of antidepressant treatment...
  2. ncbi When should a trial of fluoxetine for major depression be declared failed?
    Frederic M Quitkin
    Department of Therapeutics, New York State Psychiatric Institute, New York, NY 10032, USA
    Am J Psychiatry 160:734-40. 2003
    ..The authors sought to determine how many weeks a fluoxetine trial with no improvement should continue before treatment is changed...
  3. ncbi Predictors of relapse in a prospective study of fluoxetine treatment of major depression
    Patrick J McGrath
    Depression Evaluation Service, New York State Psychiatric Institute, 1051 Riverside Dr, New York, NY 10032 1007, USA
    Am J Psychiatry 163:1542-8. 2006
    ..This study was designed to test the predictive value of response pattern prospectively and to examine the data for other predictors of relapse...
  4. ncbi Remission rates with 3 consecutive antidepressant trials: effectiveness for depressed outpatients
    Frederic M Quitkin
    Department of Therapeutics, Columbia University College of Physicians and Surgeons, New York State Psychiatric Institute, New York, USA
    J Clin Psychiatry 66:670-6. 2005
    ..The cumulative high remission rates suggest antidepressants are effective and should encourage more patients to seek treatment and physicians to develop techniques to improve patient adherence...
  5. ncbi Electroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: pre- and post-treatment findings
    Gerard E Bruder
    Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York, New York, USA
    Biol Psychiatry 63:1171-7. 2008
    ....
  6. ncbi Psychomotor slowing as a predictor of fluoxetine nonresponse in depressed outpatients
    Bonnie P Taylor
    Depression Evaluation Service, New York State Psychiatric Institute, Department of Psychiatry, Columbia University College of Physicians and Surgeons, 1051 Riverside Dr, New York, NY 10032, USA
    Am J Psychiatry 163:73-8. 2006
    ..The authors hypothesized that since psychomotor slowing in depressed patients has been linked to reduced dopaminergic neurotransmission, patients with slowing would be unresponsive to fluoxetine, a selective serotonin reuptake inhibitor...
  7. ncbi Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions
    Jonathan W Stewart
    New York State Psychiatric Institute, United States Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY, USA
    J Affect Disord 86:161-7. 2005
    ....
  8. ncbi Dichotic listening tests of functional brain asymmetry predict response to fluoxetine in depressed women and men
    Gerard E Bruder
    Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Neuropsychopharmacology 29:1752-61. 2004
    ..Responder vs nonresponder differences for verbal dichotic listening in women and nonverbal dichotic listening in men are discussed in terms of differences in cognitive function, hemispheric organization, and neurotransmitter function...
  9. ncbi Do age of onset and course of illness define biologically distinct groups within atypical depression?
    Jonathan W Stewart
    Department of Therapeutics, New York State Psychiatric Institute and Columbia University College of Physicians and Surgeons, USA
    J Abnorm Psychol 112:253-62. 2003
    ..Course of illness may usefully define more homogeneous depressive subgroups within atypical depression...
  10. ncbi Do age of onset and course of illness predict different treatment outcome among DSM IV depressive disorders with atypical features?
    Jonathan W Stewart
    New York State Psychiatric Institute, New York, NY 10032, USA
    Neuropsychopharmacology 26:237-45. 2002
    ..Findings suggest that application of DSM IV atypical features might best be limited to those with early onset of chronic dysphoria...
  11. ncbi DSM-IV depression with atypical features: is it valid?
    Jonathan W Stewart
    Department of Depression Evaluation Service, New York State Psychiatrist Institute, New York, NY 10032, USA
    Neuropsychopharmacology 34:2625-32. 2009
    ....
  12. ncbi Does dual antidepressant therapy as initial treatment hasten and increase remission from depression?
    Jonathan W Stewart
    New York State Psychiatric Institute and Columbia University College of Physicians and Surgeons, New York, USA
    J Psychiatr Pract 15:337-45. 2009
    ..Only 30%-40% of depressed patients remit after 8 weeks of treatment with an antidepressant. We hypothesized that beginning treatment with two antidepressants would improve remission rates...
  13. ncbi "Outer-directed irritability": a distinct mood syndrome in explosive youth with a disruptive behavior disorder?
    Stephen J Donovan
    Department of Therapeutics, New York State Psychiatric Institute, New York, NY 10032, USA
    J Clin Psychiatry 64:698-701. 2003
    ....
  14. ncbi Cognitive ERPs in depressive and anxiety disorders during tonal and phonetic oddball tasks
    Gerard E Bruder
    Department of Biopsychology, New York State Psychiatric Institute, Unit 50, 1051 Riverside Drive, New York, NY 10032, USA
    Clin Electroencephalogr 33:119-24. 2002
    ....
  15. ncbi Atypical depression: enhanced right hemispheric dominance for perceiving emotional chimeric faces
    Gerard E Bruder
    Department of Biopsychology, New York State Psychiatric Institute, New York 10032, USA
    J Abnorm Psychol 111:446-54. 2002
    ..This is further evidence that atypical depression is a biologically distinct subtype and underscores the importance of this diagnostic distinction for neurophysiologic studies...
  16. ncbi Placebo-controlled continuation treatment with mirtazapine: acute pattern of response predicts relapse
    Andrew A Nierenberg
    Havard Medical School, Massachusetts General Hospital, Boston, MA 02114, USA
    Neuropsychopharmacology 29:1012-8. 2004
    ..The low relapse rate for patients with an acute placebo pattern switched to placebo suggests specific drug effect played a smaller role in their initial improvement...
  17. ncbi Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment
    David J Brunswick
    The Depression Research Unit, University of Pennsylvania Medical Center, University Science Center, 8th Floor, 3600 Market Street, Philadelphia, PA 19104, USA
    J Affect Disord 68:243-9. 2002
    ..The purpose of this study was to investigate the relationship between steady-state plasma drug concentrations and outcome during relapse-prevention therapy with fluoxetine...
  18. ncbi Early symptomatic worsening during treatment with fluoxetine in major depressive disorder: prevalence and implications
    Cristina Cusin
    Depression Clinical and Research Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    J Clin Psychiatry 68:52-7. 2007
    ..While patterns of response have been examined as possible predictors of outcome, the clinical correlates and implications of early worsening per se have not been investigated...
  19. ncbi Selecting methodologies for the evaluation of differences in time to response between antidepressants
    Stuart A Montgomery
    Imperial College School of Medicine, London, United Kingdom
    J Clin Psychiatry 63:694-9. 2002
    ..The delay in the therapeutic effect of antidepressants is a considerable impediment to their successful clinical use, and attention has recently been focused on antidepressant drugs that may have a faster onset of action...
  20. ncbi Accurate meta-analytical assessment of "true antidepressant effects" needed
    Frederic M Quitkin
    J Clin Psychiatry 66:1192; author reply 1192-3. 2005
  21. ncbi A reappraisal of atypical depression
    Frederic M Quitkin
    Am J Psychiatry 160:798-800; author reply 800-1. 2003
  22. ncbi Substance use disorder comorbidity in major depressive disorder: an exploratory analysis of the Sequenced Treatment Alternatives to Relieve Depression cohort
    Lori L Davis
    VA Medical Center, Tuscaloosa, AL 35404, USA
    Compr Psychiatry 46:81-9. 2005
    ..In conclusion, gender, marital status, age of onset of major depression, functional impairment, and suicide risk factors differ in depressed patients with concurrent SUD symptoms compared to those without SUD comorbidity...
  23. ncbi Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study
    Maurizio Fava
    Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA
    Psychiatr Clin North Am 26:457-94, x. 2003
    ..This article provides the overall rationale for STAR*D and details the rationale for key design, measurement, and analytic features of the study...
  24. ncbi Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9086, USA
    Control Clin Trials 25:119-42. 2004
    ..Participants with an adequate symptomatic response may enter the 12-month naturalistic follow-up phase with brief monthly and more complete quarterly assessments...
  25. ncbi Electrolyte-balanced sports drink for polydipsia-hyponatremia in schizophrenia
    Frederic M Quitkin
    Am J Psychiatry 160:385-6. 2003
  26. ncbi Do antihypertensives make tranylcypromine safer? Three case reports
    Bonnie P Taylor
    J Clin Psychiatry 66:657-8. 2005